Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2023
CD5L is a canonical component of circulatory IgM
Nienke Oskam, Maurits A den Boer, Marie V Lukassen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 31, 2020
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19
Erik H Vogelzang, Floris C Loeff, Ninotska I L Derksen, et al.
Ebiomedicine
|
February 26, 2025
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment
Jim B D Keijser, Eileen W Stalman, Luuk Wieske, et al.
Allergy
|
March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Anika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2023
CD5L is a canonical component of circulatory IgM
Nienke Oskam, Maurits A den Boer, Marie V Lukassen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 31, 2020
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19
Erik H Vogelzang, Floris C Loeff, Ninotska I L Derksen, et al.
Ebiomedicine
|
February 26, 2025
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment
Jim B D Keijser, Eileen W Stalman, Luuk Wieske, et al.
Allergy
|
March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Anika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Page
of 4